Chat with Filing

Ask questions about this document
Please log in or register to use the chat feature. Please register first.
TAR - FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Elstein Amir

Company: Teva Pharmaceutical Industries Ltd. Date: 2025-06-10 Language: English Register to download
Loading document preview...
Document Preview Not Available

The file type (.pdf) cannot be displayed directly here.
Open Original File
Error loading document preview. Please try the 'Open Original File' link.
You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:
Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon
| FORM 44                                                                                                                                                                                                                                                                       |            |                                                                                                                                                                                                             | OMB APPROVAL                                                           |                                                                |  |  |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------|----------------------------------------------------------------|--|--|
| Check this box if no longer subject to Section 1166<br>Form 44 or Form 55 obligations may continue See<br>Instruction 11((b))<br>Check this box to indicate that a transaction was                                                                                            |            | UNITED STATES SECURITIES AND EXCHANGE COMMISSION<br>Washington,, DC 2200554499                                                                                                                              | OMB Number::<br>Estimated average burden hours per<br>response         | 33223355--00228877<br>0055                                     |  |  |
| made pursuant to a contract,, instruction or written<br>plan for the purchase or sale of equity securities of<br>the issuer that is intended to satisfy the affirmative<br>defense conditions of Rule 1100b55--11((c)) See<br>Instruction 1100<br>((Print or Type Responses)) |            | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES<br>Filed pursuant to Section 1166((a)) of the Securities Exchange Act of 11993344 or Section 3300((h)) of the Investment Company Act of 11994400 |                                                                        |                                                                |  |  |
| 11 Name and Address of Reporting Person **<br>Elstein Amir                                                                                                                                                                                                                    |            | 22 Issuer Name and Ticker or Trading Symbol<br>Teva Pharmaceutical Industries Limited [ TEVA ]                                                                                                              | 55 Relationship of Reporting Person((s)) to Issuer<br>__ X __ Director | ((Check all applicable))<br>_____ 1100%% Owner                 |  |  |
| ((Last))<br>((First))<br>C//O Teva Pharmaceutical Industries Ltd<br>112244 Dvora HaNevi''a St,,                                                                                                                                                                               | ((Middle)) | 33 Date of Earliest Transaction ((Month//Day//Year))<br>0066//0055//22002255                                                                                                                                | _____ Officer ((give title below))<br>_____ Other ((specify below))    |                                                                |  |  |
| ((Street))                                                                                                                                                                                                                                                                    |            | 44 If Amendment,, Date Original Filed ((Month//Day//Year))                                                                                                                                                  | _ X _ Form filed by One Reporting Person                               | 66 Individual or Joint//Group Filing ((Check Applicable Line)) |  |  |

## **Table I -- Non--Derivative Securities Acquired,, Disposed of,, or Beneficially Owned**

\_\_\_ Form filed by More than One Reporting Person

Tel Aviv,, L33 66994444002200

((City)) ((State)) ((Zip))

| 11Title of Security<br>((Instr 33)) | 22 Transaction<br>Date ((Month<br>//Day//Year)) | 22A Deemed<br>Execution<br>Date,, if any<br>((Month//Day<br>//Year)) | 33 Transaction<br>Code<br>((Instr 88)) |   | 44 Securities Acquired ((A)) or<br>Disposed of ((D))<br>((Instr 33,, 44 and 55)) |                       |        | 55 Amount of Securities Beneficially Owned<br>Following Reported Transaction((s))<br>((Instr 33 and 44)) | 66<br>Ownership<br>Form::                            | 77 Nature<br>of Indirect<br>Beneficial |
|-------------------------------------|-------------------------------------------------|----------------------------------------------------------------------|----------------------------------------|---|----------------------------------------------------------------------------------|-----------------------|--------|----------------------------------------------------------------------------------------------------------|------------------------------------------------------|----------------------------------------|
|                                     |                                                 |                                                                      | Code                                   | V |                                                                                  | Amount ((A)) or ((D)) | Price  |                                                                                                          | Direct ((D))<br>or Indirect<br>((I))<br>((Instr 44)) | Ownership<br>((Instr 44))              |
| Ordinary Shares ((11))              | 0066//0066//22002255                            |                                                                      | M                                      |   | 99,,663322                                                                       | A                     | ((22)) | 22,,110033,,996633                                                                                       | D                                                    |                                        |

| Table II -- Derivative Securities Acquired,, Disposed of,, or Beneficially Owned |
|----------------------------------------------------------------------------------|
| (( eg ,, puts,, calls,, warrants,, options,, convertible securities))            |

| 11 Title of Derivative<br>Security<br>((Instr 33)) | 22 Conversion<br>33 Transaction<br>33A Deemed<br>44 Transaction<br>or Exercise<br>Date ((Month<br>Execution<br>Code<br>Price of<br>//Day//Year))<br>Date,, if any<br>((Instr 88))<br>Derivative<br>((Month//Day<br>Security<br>//Year)) |                      |      | 55 Number of<br>Derivative Securities<br>Acquired ((A)) or<br>Disposed of ((D))<br>((Instr 33,, 44,, and 55)) |              | 66 Date Exercisable and Expiration<br>Date<br>((Month//Day//Year)) |                     | 77 Title and Amount of<br>Underlying Securities<br>((Instr 33 and 44)) |                           | 88 Price of<br>Derivative<br>Security<br>((Instr 55)) | 99 Number<br>of<br>Derivative<br>Securities<br>Beneficially | 1100<br>Ownership<br>Form of<br>Derivative<br>Security::               | 1111 Nature<br>of Indirect<br>Beneficial<br>Ownership<br>((Instr 44)) |  |
|----------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|------|---------------------------------------------------------------------------------------------------------------|--------------|--------------------------------------------------------------------|---------------------|------------------------------------------------------------------------|---------------------------|-------------------------------------------------------|-------------------------------------------------------------|------------------------------------------------------------------------|-----------------------------------------------------------------------|--|
|                                                    |                                                                                                                                                                                                                                         |                      | Code | V                                                                                                             | ((A))        | ((D))                                                              | Date<br>Exercisable | Expiration Date                                                        | Title                     | Amount or<br>Number of<br>Shares                      |                                                             | Owned<br>Following<br>Reported<br>Transaction<br>((s))<br>((Instr 44)) | Direct ((D))<br>or Indirect<br>((I))<br>((Instr 44))                  |  |
| Restricted Share<br>Units                          | ((22))                                                                                                                                                                                                                                  | 0066//0066//22002255 | M    |                                                                                                               |              | 99,,663322                                                         | ((33))              | ((33))                                                                 | Ordinary<br>Shares ((11)) | 99,,663322                                            | \$\$ 00                                                     | 00                                                                     | D                                                                     |  |
| Restricted Share<br>Units                          | ((22))                                                                                                                                                                                                                                  | 0066//0055//22002255 | A    |                                                                                                               | 1144,,449922 |                                                                    | ((44))              | ((44))                                                                 | Ordinary<br>Shares ((11)) | 1144,,449922                                          | \$\$ 00                                                     | 1144,,449922                                                           | D                                                                     |  |

## **Explanation of Responses::**

**11..** The Ordinary Shares may be represented by American Depositary Shares,, each of which currently represents one Ordinary Share..

**22..** Each restricted share unit represents a contingent right to receive,, at settlement,, one ordinary share or,, at the option of the Human Resources and Compensation Committee,, the cash value of one ordinary share..

- **33..** Restricted share units were granted on June 66,, 22002244 and vested on June 66,, 22002255..
- **44..** Restricted share units were granted on June 55,, 22002255 and vest on June 55,, 22002266..

//s// Dov Bergwerk as attorney--in--fact for Amir Elstein 0066//0099//22002255

Signature of Reporting Person \*\*\*\* Date

Reminder:: Report on a separate line for each class of securities beneficially owned directly or indirectly..

**\*\*** If the form is filed by more than one reporting person,, *see* Instruction 44((b))((v))..

**\*\*\*\*** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.. *See* 1188 U..S..C.. 11000011 and 1155 U..S..C.. 7788ff((a))..

Note:: File three copies of this Form,, one of which must be manually signed.. If space is insufficient,, *see* Instruction 66 for procedure..

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number..**